IRIS Accounts Production v16.3.1.90 05119865 Board of Directors 1.1.16 31.12.16 31.12.16 false true false false false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure051198652015-12-31051198652016-12-31051198652016-01-012016-12-31051198652015-12-3105119865ns15:EnglandWales2016-01-012016-12-3105119865ns14:PoundSterling2016-01-012016-12-3105119865ns10:Director12016-01-012016-12-3105119865ns10:PrivateLimitedCompanyLtd2016-01-012016-12-3105119865ns10:SmallEntities2016-01-012016-12-3105119865ns10:AuditExempt-NoAccountantsReport2016-01-012016-12-3105119865ns10:SmallCompaniesRegimeForDirectorsReport2016-01-012016-12-3105119865ns10:SmallCompaniesRegimeForAccounts2016-01-012016-12-3105119865ns10:FullAccounts2016-01-012016-12-3105119865ns10:Director22016-01-012016-12-3105119865ns10:CompanySecretary12016-01-012016-12-3105119865ns10:RegisteredOffice2016-01-012016-12-3105119865ns5:CurrentFinancialInstruments2016-12-3105119865ns5:ShareCapital2016-12-3105119865ns5:RetainedEarningsAccumulatedLosses2016-12-3105119865ns5:PlantMachinery2015-12-3105119865ns5:PlantMachinery2016-01-012016-12-3105119865ns5:PlantMachinery2016-12-3105119865ns5:PlantMachinery2015-12-3105119865ns5:CurrentFinancialInstrumentsns5:WithinOneYear2016-12-3105119865ns5:Secured2016-12-31
REGISTERED NUMBER: 05119865 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2016

FOR

VACULEX UK LTD

VACULEX UK LTD (REGISTERED NUMBER: 05119865)






CONTENTS OF THE FINANCIAL STATEMENTS
for the Year Ended 31 December 2016




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


VACULEX UK LTD

COMPANY INFORMATION
for the Year Ended 31 December 2016







DIRECTORS: R Holmsten
D P Collins





SECRETARY:





REGISTERED OFFICE: 6th Floor
Trigate
210-222 Hagley Road West
Birmingham
West Midlands
B68 0NP





REGISTERED NUMBER: 05119865 (England and Wales)





ACCOUNTANTS: D.J. Beer & Co
335 Jockey Road
Sutton Coldfield
West Midlands
B73 5XE

VACULEX UK LTD (REGISTERED NUMBER: 05119865)

BALANCE SHEET
31 December 2016

Notes £    £   
FIXED ASSETS
Tangible assets 4 44,817

CURRENT ASSETS
Stocks 85,241
Debtors 5 445,966
531,207
CREDITORS
Amounts falling due within one year 6 522,335
NET CURRENT ASSETS 8,872
TOTAL ASSETS LESS CURRENT
LIABILITIES

53,689

CAPITAL AND RESERVES
Called up share capital 100
Retained earnings 53,589
SHAREHOLDERS' FUNDS 53,689

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2016.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2016 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors on 27 March 2017 and were signed on its behalf by:





D P Collins - Director


VACULEX UK LTD (REGISTERED NUMBER: 05119865)

NOTES TO THE FINANCIAL STATEMENTS
for the Year Ended 31 December 2016

1. STATUTORY INFORMATION

VACULEX UK LTD is a private company, limited by shares , registered in England and Wales. The company's
registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Preparation of consolidated financial statements
The financial statements contain information about VACULEX UK LTD as an individual company and do not
contain consolidated financial information as the parent of a group. The company has taken the option under
Section 398 of the Companies Act 2006 not to prepare consolidated financial statements.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates,
value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on reducing balance

Stocks
Work in progress is valued at the lower of cost and net realisable value.

Cost is calculated using the first-in, first-out method and includes all purchase, transport, and handling costs in
bringing stocks to their present location and condition.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 .

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 January 2016
and 31 December 2016 115,692
DEPRECIATION
At 1 January 2016 55,935
Charge for year 14,940
At 31 December 2016 70,875
NET BOOK VALUE
At 31 December 2016 44,817
At 31 December 2015 59,757

VACULEX UK LTD (REGISTERED NUMBER: 05119865)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 31 December 2016

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Trade debtors 378,016
Amounts owed by group undertakings 58,137
Other debtors 9,813
445,966

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Bank loans and overdrafts 53,521
Trade creditors 28,472
Amounts owed to group undertakings 98,357
Taxation and social security 129,383
Other creditors 212,602
522,335

7. SECURED DEBTS

The following secured debts are included within creditors:

£   
Bank overdraft 53,521

A debenture dated 31st October 2006 securing all monies due or due to become from the company to Nordea
Bank Plc on any account whatsoever was registered pursuant to Chapter 1 Part X11 of the Companies Act 1985
on the 3rd November 2006.

8. OTHER FINANCIAL COMMITMENTS

The accounts have been prepared on a going concern basis and the parent company Vaculex AB (Sweden) will
continue to support the UK company now and in the foreseeable future.

VACULEX UK LTD (REGISTERED NUMBER: 05119865)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 31 December 2016

9. RELATED PARTY DISCLOSURES

Mr R Holmsten is also a director of Vaculex AB (Sweden) and the following transactions were conducted on
normal commercial terms with Vaculex UK Ltd.

2016 2015
£ £

Vaculex AB (Sweden)

Purchase 383798 925578

Sales 10984 59872
Marketing support 53667 46620
Management charge 82368 0
Included in creditors is £98357 (2015 - £469878) due from Vaculex UK Ltd.


Mr D Collins who is a director of Vaculex UK Ltd has a significant influence in the running of Vaculex USA.
The following transactions were conducted on normal commercial terms.


Vaculex USA

Management re-charge 68022 58726

Marketing support 57441 51134

Included in debtors is £58137 (2015 - £85627) due to Vaculex UK Ltd.